Genoray Co. Ltd (122310) - Total Liabilities
Based on the latest financial reports, Genoray Co. Ltd (122310) has total liabilities worth ₩47.48 Billion KRW (≈ $32.17 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Genoray Co. Ltd - Total Liabilities Trend (2015–2025)
This chart illustrates how Genoray Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. See Genoray Co. Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Genoray Co. Ltd Competitors by Total Liabilities
The table below lists competitors of Genoray Co. Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Tondo Smart Ltd
TA:TNDO
|
Israel | ILA35.41 Million |
|
Tayih Lun An Co Ltd
TWO:8107
|
Taiwan | NT$1.40 Billion |
|
Progressive Planet Solutions Inc
V:PLAN
|
Canada | CA$11.35 Million |
|
Fine Metal Technologies Public Company Limited
BK:FMT
|
Thailand | ฿1.66 Billion |
|
Imugene Ltd
AU:IMU
|
Australia | AU$25.80 Million |
|
Wulff-Yhtiot Oy
HE:WUF1V
|
Finland | €38.10 Million |
|
Eduspec Holdings Bhd
KLSE:0107
|
Malaysia | RM32.07 Million |
|
Chariot Oil & Gas Limited
F:C62
|
Germany | €5.39 Million |
Liability Composition Analysis (2015–2025)
This chart breaks down Genoray Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 122310 market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.94 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.56 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.36 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Genoray Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Genoray Co. Ltd (2015–2025)
The table below shows the annual total liabilities of Genoray Co. Ltd from 2015 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩47.48 Billion ≈ $32.17 Million |
+26.43% |
| 2024-12-31 | ₩37.55 Billion ≈ $25.45 Million |
+30.68% |
| 2023-12-31 | ₩28.74 Billion ≈ $19.47 Million |
+57.59% |
| 2022-12-31 | ₩18.23 Billion ≈ $12.36 Million |
-11.29% |
| 2021-12-31 | ₩20.56 Billion ≈ $13.93 Million |
+6.96% |
| 2020-12-31 | ₩19.22 Billion ≈ $13.02 Million |
+1.51% |
| 2019-12-31 | ₩18.93 Billion ≈ $12.83 Million |
+40.58% |
| 2018-12-31 | ₩13.47 Billion ≈ $9.13 Million |
+0.24% |
| 2017-12-31 | ₩13.44 Billion ≈ $9.11 Million |
-27.72% |
| 2016-12-31 | ₩18.59 Billion ≈ $12.60 Million |
+8.17% |
| 2015-12-31 | ₩17.18 Billion ≈ $11.65 Million |
-- |
About Genoray Co. Ltd
Genoray Co., Ltd. engages in the research, development, manufacture, and sale of medical and dental x-ray devices in South Korea. It provides C-ARM and mammography medical x-ray devices; and 2D, 3D, ENT, and IOS/IOX dental x-ray devices, as well as related maintenance and repair services. The company also exports its products to approximately 80 countries worldwide. Genoray Co., Ltd. was founded … Read more